Lillian M Daughrity

7PUBLICATIONS
104CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Molecular targetsEpigenetics (incl. genome methylation and epigenomics)Liquid biopsiesNeurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 05, 2026
Blocking RAN translation without altering repeat RNAs rescues C9ORF72-related ALS and FTD phenotypes.

Xin Jiang, Laure Schaeffer, Divya Patni

|Jan 08, 2025
Dual-targeting CRISPR-CasRx reduces C9orf72 ALS/FTD sense and antisense repeat RNAs in vitro and in vivo.

Liam Kempthorne, Deniz Vaizoglu, Alexander J Cammack

|Jan 17, 2024
TMEM106B core deposition associates with TDP-43 pathology and is increased in risk SNP carriers for frontotemporal dementia.

Jordan D Marks, Virginia Estades Ayuso, Yari Carlomagno

|Oct 06, 2022
Two FTD-ALS genes converge on the endosomal pathway to induce TDP-43 pathology and degeneration.

Wei Shao, Tiffany W Todd, Yanwei Wu

|Oct 22, 2020
Toward allele-specific targeting therapy and pharmacodynamic marker for spinocerebellar ataxia type 3.

Mercedes Prudencio, Hector Garcia-Moreno, Karen R Jansen-West

|Sep 04, 2020
C9orf72 poly(GR) aggregation induces TDP-43 proteinopathy.

Casey N Cook, Yanwei Wu, Hana M Odeh

Pageof 2